Inovio Pharmaceuticals's total assets for Q2 2025 were $68.24M, a decrease of -21.81% from the previous quarter. INO total liabilities were $39.71M for the fiscal quarter, a 10.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.